| Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis DS Mysiris, GD Vavougios, E Karamichali, S Papoutsopoulou, VT Stavrou, ... International journal of molecular sciences 23 (17), 9739, 2022 | 13 | 2022 |
| Breathlessness and exercise with virtual reality system in long-post-coronavirus disease 2019 patients VT Stavrou, GD Vavougios, P Kalogiannis, K Tachoulas, E Touloudi, ... Frontiers in public health 11, 1115393, 2023 | 7 | 2023 |
| Parkinson’s Disease, It Takes Guts: The Correlation between Intestinal Microbiome and Cytokine Network with Neurodegeneration G Xiromerisiou, C Marogianni, A Androutsopoulou, P Ntavaroukas, ... Biology 12 (1), 93, 2023 | 4 | 2023 |
| Cognitive impairment in COVID‐19 Survivors: Analysis and Extensions on Population Studies in Greece GD Vavougios, V Stavrou, D Mysiris, S Boutlas, E Papayianni, ... Alzheimer's & Dementia 18, e066877, 2022 | 1 | 2022 |
| Physical fitness, respiratory and cognitive profile in POST-COVID-19 patients and associations with OSAS risk strata K Astara, V Stavrou, G Vavougios, E Papayianni, G Tsirimona, D Mysiris, ... Journal of Sleep Research, 2022 | 1 | 2022 |
| SARS‐CoV‐2 Associated Neurocognitive Disorder (SAND): Molecular validation of a pathogenetic hypothesis GD Vavougios, D Mysiris, P Foka, T Mavridis, V Stavrou, O Papaggeli, ... Alzheimer's & Dementia 19, e077044, 2023 | | 2023 |
| Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up G Xiromerisiou, IC Lampropoulos, EV Dermitzakis, M Vikelis, ... Toxins 15 (9), 539, 2023 | | 2023 |
